Literature DB >> 22560714

Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans.

Martin Stuschke1, Andreas Kaiser, Christoph Pöttgen, Wolfgang Lübcke, Jonathan Farr.   

Abstract

BACKGROUND AND
PURPOSE: The potentials of lung sparing, dose escalation, and the robustness of intensity modulated proton plans (IMPT(robust)), obtained by minimax optimization on multiple scenarios, were studied.
MATERIALS AND METHODS: IMPT(robust) optimization as described by Fredriksson et al. [23] was evaluated by means of comparative treatment planning using breath hold CT data from 6 non-small cell lung cancer (NSCLC) patients. IMPT(robust) and single field uniform dose (SFUD) proton plans were compared to Tomotherapy and 7-field intensity modulated photon therapy (IMXT). Plan robustness against set-up errors, range uncertainties, and between field motions were analyzed as well as lung exposure quantified by the mean lung dose (MLD) and the partial lung volumes receiving at least 20, 10, and 5 Gy(RBE) (V20, V10, V5). Robustness was analyzed with regard to stability of the effective uniform dose (EUD) and the dose level reached or exceeded in 95% of the CTV (D95).
RESULTS: MLD by IMPT(robust) was less than by SFUD, and Tomotherapy in each patient, on average by 14.8% and 28.5% (p<0.05, Friedman test). V20-V5 were higher with Tomotherapy compared to both proton therapy techniques, on average by a factor of >1.8. Robustness of IMPT(robust) was high. EUD and D95 values were maintained above 96% and 94% of the reference plan values for all tested scenarios. With dose escalation to 86 Gy(RBE) lung tissue tolerances were maintained.
CONCLUSIONS: IMPT(robust) proved advantageous in terms of lung exposure and possible dose escalation while being also markedly robust. However, motion during delivery of a field remains a major problem of IMPT(robust) to be mitigated by high scanning speed and variable spot size.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22560714     DOI: 10.1016/j.radonc.2012.03.017

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  31 in total

1.  Robust optimization for intensity-modulated proton therapy with soft spot sensitivity regularization.

Authors:  Wenbo Gu; Dan Ruan; Daniel O'Connor; Wei Zou; Lei Dong; Min-Yu Tsai; Xun Jia; Ke Sheng
Journal:  Med Phys       Date:  2019-01-21       Impact factor: 4.071

2.  Clinical implementation of intensity modulated proton therapy for thoracic malignancies.

Authors:  Joe Y Chang; Heng Li; X Ronald Zhu; Zhongxing Liao; Lina Zhao; Amy Liu; Yupeng Li; Narayan Sahoo; Falk Poenisch; Daniel R Gomez; Richard Wu; Michael Gillin; Xiaodong Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-09-24       Impact factor: 7.038

3.  PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.

Authors:  Wei Liu; Steven J Frank; Xiaoqiang Li; Yupeng Li; Ron X Zhu; Radhe Mohan
Journal:  Med Phys       Date:  2013-02       Impact factor: 4.071

4.  Robust optimization in IMPT using quadratic objective functions to account for the minimum MU constraint.

Authors:  Jie Shan; Yu An; Martin Bues; Steven E Schild; Wei Liu
Journal:  Med Phys       Date:  2017-12-05       Impact factor: 4.071

5.  Dosimetric benefits of robust treatment planning for intensity modulated proton therapy for base-of-skull cancers.

Authors:  Wei Liu; Radhe Mohan; Peter Park; Zhong Liu; Heng Li; Xiaoqiang Li; Yupeng Li; Richard Wu; Narayan Sahoo; Lei Dong; X Ronald Zhu; David R Grosshans
Journal:  Pract Radiat Oncol       Date:  2014-01-14

6.  Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer.

Authors:  Joe Y Chang; Wencheng Zhang; Ritsuko Komaki; Noah C Choi; Shen Chan; Daniel Gomez; Michael O'Reilly; Melenda Jeter; Michael Gillin; Xiaorong Zhu; Xiaodong Zhang; Radhe Mohan; Stephen Swisher; Stephen Hahn; James D Cox
Journal:  Radiother Oncol       Date:  2017-01-28       Impact factor: 6.280

7.  Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.

Authors:  Wei Liu; Steven E Schild; Joe Y Chang; Zhongxing Liao; Yu-Hui Chang; Zhifei Wen; Jiajian Shen; Joshua B Stoker; Xiaoning Ding; Yanle Hu; Narayan Sahoo; Michael G Herman; Carlos Vargas; Sameer Keole; William Wong; Martin Bues
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-11-10       Impact factor: 7.038

8.  Proton energy optimization and reduction for intensity-modulated proton therapy.

Authors:  Wenhua Cao; Gino Lim; Li Liao; Yupeng Li; Shengpeng Jiang; Xiaoqiang Li; Heng Li; Kazumichi Suzuki; X Ronald Zhu; Daniel Gomez; Xiaodong Zhang
Journal:  Phys Med Biol       Date:  2014-10-08       Impact factor: 3.609

9.  Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.

Authors:  Chenbin Liu; Steven E Schild; Joe Y Chang; Zhongxing Liao; Shawn Korte; Jiajian Shen; Xiaoning Ding; Yanle Hu; Yixiu Kang; Sameer R Keole; Terence T Sio; William W Wong; Narayan Sahoo; Martin Bues; Wei Liu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-02-14       Impact factor: 7.038

10.  Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.

Authors:  Jie Shan; Yunze Yang; Steven E Schild; Thomas B Daniels; William W Wong; Mirek Fatyga; Martin Bues; Terence T Sio; Wei Liu
Journal:  Med Phys       Date:  2020-10-13       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.